OTC •
Healthcare •
Biotechnology •
Quote as of 05/15/2026 10:01
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization7.54 mln
Float54.97 mln
Earnings Date05/15/2026
Relative Strength
86
/ 100
Strongly outperforming
Debt / Equity
0.00
Debt-free
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
ROA
-248
Deeply negative
Business Description
Nymox Pharmaceutical Corporation is a drug research company focused on developing medical treatments for health conditions that commonly affect older adults. Its primary area of work centers on a drug designed to address prostate enlargement and certain forms of prostate and liver cancer. The company also works on treatments aimed at slowing or preventing Alzheimer's disease, and sells testing products that measure a person's exposure to cigarette smoke. Founded in 1989, Nymox operates out of Nassau, Bahamas.
